Diagnostics

Development of new diagnostic tools for infectious diseases

High content serology screenings

In the lab we use high-density peptide microarrays to discover new antigens, map their epitopes and to perform very fine epitope characterizations. This produces very rich data on human immune responses and their targets. Then, these antigens and epitopes are synthesized and used as reagents for the development of new immunoassays.

Next-generation diagnostic assays

Novel diagnostic reagents based on small peptides or recombinant proteins are produced in the lab, and validated for a number of applications: diagnosis of infection; as prognostic markers (to predict development of pathology); or as markers to followup treatments and cure.

Avatar
Fernán Agüero
Principal Investigator, Assistant Professor

Using and generating data to guide discovery of new drugs and diagnostics.

Avatar
Emir Salas Sarduy
Associate Investigator

Passionate about enzymes and drug discovery.

Avatar
Leonel Bracco
PhD Student

PhD Fellow and teaching assistant.

Avatar
Alejandro Ricci
PhD Student

PhD Fellow. Processing big data to draw biological conclusions.

Related